HONG KONG, July 26, 2022 – (ACN Newswire) – The aging of the population is accelerating, pharmaceutical technology is constantly updating, and the development of the…
Foster City, CA, and Hangzhou, China, Jul 26, 2022 – (ACN Newswire via SEAPRWire.com) – Apollomics Inc. an innovative biopharmaceutical company committed to the discovery…
TOKYO, May 17, 2022 – (JCN Newswire via SEAPRWire.com) – Fujitsu Limited and RIKEN today launched a joint research project on next-generation IT drug discovery…
Tokyo and Reykjavík, Iceland, Apr 13, 2022 – (JCN Newswire via SEAPRWire.com) – Fujitsu and Atmonia ehf., an Icelandic start-up company developing a sustainable process…
Foster City, CA, Shanghai and Hangzhou, China, Jan 12, 2022 – (ACN Newswire via SEAPRWire.com) – Apollomics Inc. an innovative biopharmaceutical company committed to the…
LONDON, Oct 19, 2021 – (ACN Newswire via SEAPRWire.com) – WARC, in partnership with TikTok (www.tiktok.com) and Publicis Groupe (www.publicisgroupe.com/fr/splash), have today released a new…
TOKYO, Apr 7, 2021 – (JCN Newswire via SEAPRWire.com) – Hitachi, Ltd. (TSE:6501) and Axcelead, Inc. today announced that they have agreed on a comprehensive…
TOKYO, Nov 30, 2020 – (JCN Newswire) – Eisai Co., Ltd. and Wren Therapeutics Ltd. today announced that the companies have entered into an exclusive…
TOKYO, Nov 13, 2020 – (JCN Newswire) – PeptiDream Inc., a public Kanagawa-based biopharmaceutical company (TSE:4587), Fujitsu Limited (TSE:6702), Mizuho Capital Co., Ltd. which is…